Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sharon Shacham files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Peter Blume-Jensen - $117K in ACRV purchases and sales in the last 12 months
- Eric Devroe - $18K in ACRV purchases and sales in the last 12 months
- Adam D. Levy - $17K in ACRV purchases and sales in the last 12 months
- Mary Miller - $2K in ACRV purchases and sales in the last 12 months
- Erick Gamelin - $804 in ACRV purchases and sales in the last 12 months
- Katharine Peterson - $203 in ACRV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sharon Shacham?
Sharon Shacham is a corporate insider of Acrivon Therapeutics, Inc. (ACRV). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Sharon Shacham last file a Form 4?
The most recent primary Form 4 on record is dated 22 June 2026, one of 2 filings going back to 2026.
